PMHS Polomar Health Services, Inc.

Overview and Growth

Fiscal 2025 results for Polomar Health Services, Inc. combined $648.23K of revenue with net loss of $10.70M and an operating cash outflow of $396.00K. Revenue of $648.23K sets the scale for evaluating how effectively sales translated into profit and cash during the year. On a per-share basis, diluted EPS was -$0.39, which connects the reported earnings outcome with the company’s diluted share count. Diluted shares averaged 27.76M; this is the reported share base over which the company’s diluted per-share earnings were spread. Diluted shares moved 0.4% from 27.66M in fiscal 2024, leaving the current share base higher year over year. Total assets stood at $390.04K, showing the scale of resources supporting revenue, earnings, liquidity, and financing. Asset turnover was 1.66x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $460.10K as gross profit before recognizing operating expenses and other items. Gross profit represented 71.0% of revenue, showing how much of the top line remained after direct costs. The reported operating result was an operating loss of $10.55M, reflecting costs that exceeded gross profit. The company ended the period with a net loss of $10.70M, extending the operating result through all remaining items. The company reported negative EBITDA of $776.94K, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. Compared with a $1.34M net loss in fiscal 2024, the current loss increased to $10.70M.

Liquidity and Capital Structure

At period end, the $390.04K asset base was financed through $1.61M of liabilities and -$1.22M of equity. The company reported negative equity of -$1.22M, a capital deficit that reduces its ability to absorb losses through book equity. At period end, current assets of $322.73K compared with current liabilities of $1.61M, defining the company’s short-term resource position. Current assets covered only 0.2x of current liabilities, so current liabilities exceeded current assets at period end. The company held $132.15K in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 8.2%, excluding receivables and other current assets. Book equity represented -313.4% of total assets, quantifying the balance-sheet share supported by shareholder capital. Relative to total assets, liabilities measured 413.4%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 33.9%, a balance-sheet composition measure rather than a liquidity forecast. The asset base changed 96.1% from $9.95M in fiscal 2024, leaving current total assets lower year over year. Against $8.60M of equity in fiscal 2024, the current book-equity balance moved 114.2% and ended lower.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $396.00K, rather than cash generation from operations. Cash absorbed by operations decreased from $1.02M in fiscal 2024 to $396.00K.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Sep 24, 2026.